. Why are so few antipsychotic drugs licensed for Alzheimer's disease related behavioral and psychological symptoms?. Expert Rev Neurother. 2019 Nov;19(11):1051-1053. Epub 2019 Jul 15 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.